Tengjun Biotechnology Corp.

TJBHOTCConsumer Defensive

$2.00

+$0.00(+0.00%)

Market Cap$201422000

P/E Ratio—

52W High$2

52W Low$2

Avg Volume12

Open$2.00

Beta-1.02

Overview

Tengjun Biotechnology Corp. (TJBH) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

TJBH · net income · updated Jun 15, 2026

Core profitability metrics

TJBH · net income · margin · TTM · CAGR

Net income was $11.3M for FY2022 (fiscal year ending 2022-12-31), up 1616.6% year-over-year. Net profit margin was 7.6%. Based on available data, Tengjun Biotechnology Corp. has been profitable since at least 2022.

FY2022 Net Income$11.3M▲ +1616.6% YoY

Trailing 12M (TTM)$7.1Mtrailing 4 quarters sum

Net Profit Margin7.6%$11.3M ÷ $150.1M

YoY Change+1616.6%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 15, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2022

▸ FMP /income-statement · Annual · TJBH net income history · TJBH profit margin

Annual net income data

TJBH · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2022★ First Profit$11.3M▲ +1616.6%7.6%$150.1M

FY2021Loss−$748,174▼ 8.3%—$0

FY2020Loss−$690,886▼ 761.1%-238236.5%$290

FY2019Loss−$80,237▼ 67.8%—$0

FY2018Loss−$47,806▲ +0.9%—$0

Net income vs peers (Consumer Defensive)

TJBH vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Tengjun Biotechnology Corp.YOU

TJBH

$11.3M+1616.6%7.6%

The Procter & Gamble Company

$15.97B+7.4%18.9%

73%

The Coca-Cola Company

$13.11B+23.3%27.3%

60%

Philip Morris International Inc.

$11.35B+61.3%27.9%

52%

Costco Wholesale Corporation

COST

$8.10B+9.9%2.9%

37%

Consumer Defensive · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Tengjun Biotechnology Corp. (TJBH) reported net income of $11.3M for FY2022 (fiscal year ending 2022-12-31), up 1616.6% year-over-year. The net profit margin was 7.6% — meaning the company kept $0.08 of every dollar of revenue as profit.

Based on available data, Tengjun Biotechnology Corp. has been profitable since at least 2022. Net income reached a peak of $11.3M in FY2022. Data available for 12 fiscal years.

Tengjun Biotechnology Corp.'s net profit margin was 7.6% for FY2022, based on the latest annual results.

Investors sometimes search for "Tengjun Biotechnology Corp. net worth" — the company's market capitalization is a separate figure from TJBH net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

TJBH net income · 5 questions

Tengjun Biotechnology Corp. is profitable. The company reported net income of $11.3M for FY2022, a net profit margin of 7.6%. Net income was up 1616.6% year-over-year. Based on available data, Tengjun Biotechnology Corp. has been profitable since at least 2022.

is TJBH profitabledoes TJBH make a profitTJBH profitabilityTJBH profitable company

▸ Source: FMP /income-statement · GAAP · Tengjun Biotechnology Corp. · Tengjun Biotechnology Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026